Gut bacteria therapy takes on superbugs in new trial

NCT ID NCT06321536

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving a special mix of gut bacteria (microbiota therapy) can safely reduce the amount of drug-resistant germs living in the gut. About 60 adults who carry these superbugs will either receive the treatment or be observed. The goal is to see if the therapy can clear the resistant bacteria without causing serious side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTI-DRUG RESISTANT ORGANISM COLONIZATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • A.G Rhodes Wesley Woods

    RECRUITING

    Atlanta, Georgia, 30329, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Emory Long Term Acute Care (LTAC)

    RECRUITING

    Decatur, Georgia, 30030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Penn Medicine Rittenhouse

    RECRUITING

    Philadelphia, Pennsylvania, 19146, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • RML Specialty Hospital

    RECRUITING

    Hinsdale, Illinois, 60521, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••